Committee speaker index
Letter: E
Elliott, Hon. C. (PC, Newmarket–Aurora)
- Advertising
- jurisdiction over, E52
- Alternate-level-of-care (ALC), E6, E62
- Ambulance services
- land ambulances
- government funding, E43
- land ambulances
- Auditor General
- reports
- 2017 Annual Report: Ch. 3.10 - Public Health: Chronic Disease Prevention, E49–E50
- reports
- Business - COVID-19
- Cancer Care Ontario
- general remarks, E31–E32
- Consumption and treatment services
- Consumption and treatment services - sites
- COVID-19
- COVID-19 modelling, EM67–EM68, EM73–EM74, EM77–EM78, EM82
- COVID-19 - transmission
- COVID-19 - vaccination
- Crisis services
- mobile crisis teams, E14
- Dental care
- Emergency orders review, EM56, EM58–EM59, EM61–EM64, EM66
- Government expenditures
- budget allocation
- health and long-term care, E5
- budget allocation
- Health care - administration
- Health care services - delivery
- Health care system
- patient navigation of, E5–E6
- Health care system - digital reforms, E6, E12
- Health care system - reform
- Health professionals
- scopes of practice
- expansion of, E16
- scopes of practice
- Home and community care
- Home and community care - administration
- care coordinators, E65
- Home and community care - funding
- Hospital funding
- Hospital services
- Hospitals
- Long-term care - administration
- licensing applications
- temporary emergency licences, E15
- licensing applications
- Long-term care - funding
- government funding, E34
- Long-term-care beds
- Long-term-care facilities - new, E14–E15
- Mental health and addictions
- Mental Health and Addictions Centre of Excellence
- Mental health and addictions funding, E13, E27
- Mental health and addictions funding - children and youth, E31
- school vs. community allocation, E31
- Mental health and addictions services
- Mental health and addictions services - service delivery
- general remarks, E47
- Ministry of Health and Long-Term Care
- OHIP+: Children and Youth Pharmacare Program
- Ontario Drug Benefit Program
- formulary
- new drug coverage, E71
- formulary
- Ontario Health
- Ontario health teams
- Ontario health teams - administration and governance
- Opioid addiction
- cost to health care system, E34
- Opioids
- manufacturer liability lawsuits
- general remarks, E34
- manufacturer liability lawsuits
- Palliative care
- home vs. community
- availability, E41
- home vs. community
- People's Health Care Act, 2019 (Bill 74)
- proclamation of, E17
- Personal health information
- patient access, E68
- Prescription drugs
- coverage through Trillium Drug Program, E11
- Public health - funding
- Public health - programs
- Public health units
- Smoke-Free Ontario Act, 2017, S.O. 2017, c. 26, Sched. 3
- general remarks, E25
- Trillium Drug Program
- as backstop for coverage gaps, E11
- Vaping
- pulmonary illness due to
- reporting requirements, E52
- pulmonary illness due to
- Vaping and youth
- prevalence, E52
- Vaping products
- Advertising
Last updated